NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ICAD

Icad Inc

Jul 03 • 01:30PM ET

3.76

Dollar change +0.02
Percentage change 0.53	%

Healthcare • Medical Devices • USA • NASD

Peers: HOLX ARVN MMSI BIO PEN CGEN IDXX SRTS LMT BFLY

| Held by: VTI VXF IWC AVSC DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.20	Insider Own	5.71%	Shs Outstand	27.18M	Perf Week	-2.59%
Market Cap	103.29M	Forward P/E	-	EPS next Y	-0.12	Insider Trans	0.00%	Shs Float	25.90M	Perf Month	-3.59%
Enterprise Value	83.57M	PEG	-	EPS next Q	-0.06	Inst Own	29.41%	Short Float	1.04%	Perf Quarter	92.82%
Income	-5.23M	P/S	5.29	EPS this Y	15.00%	Inst Trans	47.22%	Short Ratio	0.33	Perf Half Y	96.34%
Sales	19.53M	P/B	3.32	EPS next Y	32.35%	ROA	-13.09%	Short Interest	0.27M	Perf YTD	105.46%
Book/sh	1.13	P/C	5.16	EPS next 5Y	-	ROE	-16.53%	52W High	4.01 -6.35%	Perf Year	197.23%
Cash/sh	0.73	P/FCF	-	EPS past 3/5Y	22.27% 21.98%	ROIC	-16.94%	52W Low	1.18 218.64%	Perf 3Y	-8.07%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-16.47% -8.95%	Gross Margin	84.36%	Volatility	2.76% 3.36%	Perf 5Y	-62.32%
Dividend TTM	-	EV/Sales	4.28	EPS Y/Y TTM	-68.28%	Oper. Margin	-30.50%	ATR (14)	0.13	Perf 10Y	4.44%
Dividend Ex-Date	-	Quick Ratio	3.57	Sales Y/Y TTM	-0.53%	Profit Margin	-26.77%	RSI (14)	51.35	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.66	EPS Q/Q	32.76%	SMA20	-0.88%	Beta	1.43	Target Price	3.75
Payout	-	Debt/Eq	0.01	Sales Q/Q	-1.61%	SMA50	1.21%	Rel Volume	0.23	Prev Close	3.74
Employees	66	LT Debt/Eq	0.00	Earnings	May 13 AMC	SMA200	49.95%	Avg Volume	811.00K	Price	3.76
IPO	Dec 13, 1984	Option/Short	Yes / Yes	EPS/Sales Surpr.	68.00% 7.39%	Trades		Volume	189,085	Change	0.53%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-25	Downgrade	Laidlaw	Buy → Hold
Apr-17-25	Downgrade	BTIG Research	Buy → Neutral
Jan-18-22	Downgrade	Guggenheim	Buy → Neutral
Apr-22-21	Initiated	Guggenheim	Buy	$24
Mar-23-21	Initiated	BTIG Research	Buy	$25
Feb-26-21	Initiated	Oppenheimer	Outperform	$27
Jan-29-21	Initiated	Cantor Fitzgerald	Overweight	$19
Dec-03-20	Initiated	B. Riley Securities	Buy	$15
Feb-05-20	Initiated	JMP Securities	Mkt Outperform	$15
Jan-09-20	Initiated	Lake Street	Buy	$14
Dec-09-08	Reiterated	Canaccord Adams	Buy	$5 → $3.50
Aug-01-08	Reiterated	MDB Capital Group	Buy	$5.50 → $6
May-14-08	Reiterated	Canaccord Adams	Buy	$4 → $4.50
Feb-14-08	Initiated	Sun Trust Rbsn Humphrey	Buy	$4
Jan-24-07	Reiterated	Dawson James	Speculative Buy	$4 → $5

Show Previous Ratings

May-13-25 04:17PM	Icad: Q1 Earnings Snapshot (Associated Press Finance) +5.93%
04:01PM	iCAD Reports Financial Results for First Quarter Ended March 31, 2025 (GlobeNewswire)
11:28AM	Behind the FDA's AI Push: A Growing Class of Public Healthcare Innovators (PR Newswire)
Apr-30-25 10:53AM	iCAD and Microsoft join forces for AI mammography solutions (Medical Device Network)
Apr-29-25 11:12AM	Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds (PR Newswire)
08:00AM	Loading…
08:00AM	iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft's Precision Imaging Network (PIN) (GlobeNewswire)
Apr-15-25 04:01PM	RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer (GlobeNewswire) +6.04% +59.07%
Apr-08-25 10:19AM	iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer (GlobeNewswire)
Mar-20-25 03:02AM	icad Inc (ICAD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic SaaS ... (GuruFocus.com) -15.38%
Mar-19-25 07:01PM	ICAD targets SaaS growth with ProFound Cloud expansion and AI advancements (SeekingAlpha) +6.47%
07:00PM	iCAD, Inc. (ICAD) Q4 2024 Earnings Call Transcript (SeekingAlpha)
04:17PM	Icad: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024 (GlobeNewswire)
Mar-11-25 08:00AM	iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025 (GlobeNewswire)
Mar-05-25 02:04PM	iCAD and RamSoft Announce Partnership to Deliver ProFound AI-Powered Mammography Solutions Across North America (GlobeNewswire)
05:55PM	Loading…
Feb-27-25 05:55PM	iCAD, Inc. (ICAD) and Koios Partner to Enhance AI-Powered Breast Cancer Detection (Insider Monkey) -5.16%
Feb-26-25 02:46PM	Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025 (GlobeNewswire)
Feb-21-25 07:59AM	iCAD, Inc. (ICAD): A Bull Case Theory (Insider Monkey)
Feb-20-25 11:44AM	iCAD, Inc. (ICAD) to Showcase AI-Powered Breast Health Innovations at ECR 2025 (Insider Monkey) -6.60%
Feb-19-25 08:00AM	iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025 (GlobeNewswire)
Feb-03-25 07:12PM	Why iCAD Inc (ICAD) Is Skyrocketing So Far In 2025 (Insider Monkey) +7.84%
Jan-27-25 09:31AM	Why ICAD Stock Is Climbing Today (Insider Monkey) +17.77%
08:00AM	iCAD Pre-Announces Estimated Q4 2024 Revenue (GlobeNewswire)
Dec-11-24 10:00AM	SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations (GlobeNewswire)
Dec-04-24 05:00PM	CORRECTION - iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024 (GlobeNewswire)
Nov-26-24 01:00PM	iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024 (GlobeNewswire) +9.49%
Nov-14-24 11:22AM	Q3 2024 ICAD Inc Earnings Call (Thomson Reuters StreetEvents) -23.72%
Nov-13-24 04:12PM	Icad: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	iCAD Reports Financial Results for Third Quarter Ended September 30, 2024 (GlobeNewswire)
Nov-12-24 08:00AM	iCAD's ProFound Detection Version 4.0 Gains FDA Clearance (GlobeNewswire) +13.74%
08:00AM	Loading…
Nov-06-24 08:00AM	iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference (GlobeNewswire)
Nov-05-24 08:00AM	iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024 (GlobeNewswire)
Oct-24-24 02:00PM	ICAD, Inc. (ICAD): A Bull Case Theory (Insider Monkey) +6.86%
Oct-16-24 08:00AM	iCAD to Participate in the LD Micro Main Event XVII (Newsfile) +22.64%
Oct-09-24 06:19PM	icad Inc (ICAD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts (GuruFocus.com)
Oct-03-24 08:00AM	iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024 (GlobeNewswire)
Sep-20-24 08:00AM	iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024 (ACCESSWIRE)
Sep-11-24 08:00AM	iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024 (GlobeNewswire)
Aug-13-24 04:14PM	Icad: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	iCAD Reports Financial Results for Second Quarter Ended June 30, 2024 (GlobeNewswire)
Aug-06-24 08:00AM	iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024 (GlobeNewswire) -5.51%
Jul-29-24 08:00AM	iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography (GlobeNewswire)
Jun-26-24 08:00AM	iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024 (GlobeNewswire)
Jun-04-24 08:00AM	iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference (GlobeNewswire)
May-17-24 07:00AM	3 Top Small-Cap Growth Opportunities in the AI Era (InvestorPlace)
May-16-24 03:01AM	icad Inc (ICAD) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth and Operational ... (GuruFocus.com) +8.59%
May-15-24 11:52AM	ICAD Stock Earnings: icad Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00AM	iCAD Reports Financial Results for First Quarter Ended March 31, 2024 (GlobeNewswire)
07:57AM	Icad: Q1 Earnings Snapshot (Associated Press Finance)
May-08-24 09:49AM	UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 (GlobeNewswire)
May-02-24 08:00AM	iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 (GlobeNewswire)
Apr-11-24 08:00AM	iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium (GlobeNewswire)
Apr-09-24 08:00AM	iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation (GlobeNewswire) +10.43%
Apr-08-24 04:29PM	iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting (GlobeNewswire)
Apr-03-24 08:00AM	iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs) (GlobeNewswire) +18.75%
Apr-02-24 08:00AM	iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale (GlobeNewswire) +5.26%
Mar-19-24 09:00AM	iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists (GlobeNewswire)
Mar-14-24 02:00PM	Artificial Intelligence, Real Profits: 3 Stocks to Outsmart the Market (InvestorPlace) -10.56%
Mar-13-24 08:46AM	iCAD, Inc. (NASDAQ:ICAD) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:01AM	Q4 2023 ICAD Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-12-24 04:22PM	Icad: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Mar-01-24 07:30AM	The Hot List: 3 AI Stocks Worth Buying on Weakness (InvestorPlace)
Feb-28-24 08:05AM	iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings (GlobeNewswire) +12.10%
Feb-27-24 09:05AM	iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.c ) (GlobeNewswire)
08:05AM	iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 (GlobeNewswire)
Feb-06-24 08:00AM	iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-30-24 08:00AM	iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member (GlobeNewswire)
Dec-18-23 08:00AM	iCAD Expands Executive Sales Leadership Team as Business Grows (GlobeNewswire)
Dec-05-23 06:00AM	Wealth Accumulation: 3 Stocks with Multibagger Potential (InvestorPlace)
Nov-28-23 08:00AM	iCAD's AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare (GlobeNewswire) +14.60%
Nov-27-23 08:00AM	iCAD's ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease (GlobeNewswire)
Nov-22-23 08:12AM	Discover Future Growth Stocks: 3 Penny Stocks Poised for Massive Returns (InvestorPlace)
Nov-20-23 08:00AM	iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution (GlobeNewswire)
Nov-14-23 10:56AM	iCAD, Inc. (NASDAQ:ICAD) Q3 2023 Earnings Call Transcript (Insider Monkey) -6.99%
08:00AM	iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference (GlobeNewswire)
Nov-13-23 04:06PM	Icad: Q3 Earnings Snapshot (Associated Press Finance) +6.72%
04:01PM	iCAD Reports Financial Results for Third Quarter Ended September 30, 2023 (GlobeNewswire)
Oct-30-23 08:00AM	iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023 (GlobeNewswire)
Oct-24-23 04:03PM	The 7 Most Undervalued AI Penny Stocks to Buy: October 2023 (InvestorPlace) -5.41%
Oct-23-23 08:01AM	iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta (GlobeNewswire) -5.00%
Oct-08-23 07:19PM	7 Trailblazing AI Stocks to Buy on Any Weakness (InvestorPlace)
Sep-01-23 05:07AM	3 Up-and-Coming Stocks to Put on Your Must-Buy List (InvestorPlace)
Aug-27-23 11:53AM	10 Best AI Penny Stocks to Buy Now (Insider Monkey)
Aug-16-23 08:00AM	Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment (GlobeNewswire)
Aug-15-23 07:58AM	Q2 2023 ICAD Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 05:48PM	Icad: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	iCAD Reports Financial Results for Second Quarter Ended June 30, 2023 (GlobeNewswire)
08:00AM	iCAD and Google Health Expand Integration of Googles AI Technology with iCADs ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader (GlobeNewswire)
Aug-07-23 11:49AM	5 AI Stocks That Could Turn $50,000 Into $1 Million (InvestorPlace) -7.78%
Jul-31-23 08:00AM	iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023 (GlobeNewswire) -5.78%
Jul-25-23 09:34PM	If You Can Only Buy One Tech Stock, It Better Be One of These 7 Names (InvestorPlace)
Jul-23-23 09:49AM	Investors in iCAD (NASDAQ:ICAD) from three years ago are still down 63%, even after 80% gain this past week (Simply Wall St.)
Jul-18-23 08:00AM	iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nations Largest Radiology Practice (GlobeNewswire) +74.27%
Jul-12-23 08:00AM	iCADs ProFound Insights, ProFound Impact Webinar Series to Feature Cleveland Clinic (GlobeNewswire)
Jul-10-23 08:00AM	iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting (GlobeNewswire) +17.77%
Jul-07-23 02:30PM	7 Stocks to Target for Triple-Digit Returns in 2023 (InvestorPlace) +7.07%
Jun-25-23 02:17PM	CEO Shuffle: 7 Stocks That Could Gain Momentum From New Leadership (InvestorPlace)
Jun-08-23 06:31AM	There Is A Reason iCAD, Inc.'s (NASDAQ:ICAD) Price Is Undemanding (Simply Wall St.)
May-18-23 04:40PM	3 High-Reward Stocks Riding the AI Boom (InvestorPlace) +8.43%

iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICAD

Icad Inc

Upgrade your FINVIZ experience